https://www.selleckchem.com/products/sp2509.html
lli," Naples, Italy, and by the institutional review board (IRB Min. no. 9926 dated 05.05.2018). To compare glycemic variability (GV) and time in range (TIR) in Chinese patients with type 2 diabetes (T2D) initiated on once-daily bedtime insulin glargine 300U/ml (Gla-30 versus neutral protamine Hagedorn (NPH) insulin using continuous glucose monitoring (CGM). This was a 24-week, open-label exploratory study with 11 randomization comparing patient-adjusted titration of Gla-300 (n = 23) versus NPH (n = 23) at bedtime in insulin-naïve T2D
Like
Comment
Share
